Skip to main content
OpenTrials

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,460 public trials 133 recruiting studies
Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

NCT05453578

Conditions
Bacterial Disease Carrier, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
Locations
  • The University of Arizona - Banner University Medical Center Tucson Campus - Tucson Tucson, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • University of California, San Diego (UCSD) - Antiviral Research Center (AVRC) La Jolla, California, United States
  • University of California Los Angeles Medical Center - Westwood Clinic Los Angeles, California, United States
View all 19 locations
View Trial Details
Completed

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

NCT06369220

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Chlamydia Trachomatis Infection, +14 more
Locations
  • San Francisco City Clinic San Francisco, California, United States
  • Planned Parenthood of Northern, Central, and Southern New Jersey, Inc. Hamilton Square, New Jersey, United States
  • Planned Parenthood of Northern, Central and Southern New Jersey Perth Amboy, New Jersey, United States
  • Baylor Scott & White Health - Kileen Killeen, Texas, United States
View Trial Details
Completed

A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants

NCT05082285

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Santo Domingo Este, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 33 locations
View Trial Details
Completed

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

NCT06016088

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bronchial Diseases, +27 more
Locations
  • Tucson Cystic Fibrosis Center Tucson, Arizona, United States
  • Center for Cystic Fibrosis at Keck Medical Center of USC Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Augusta University Augusta, Georgia, United States
View all 22 locations
View Trial Details

Related conditions